Suppliers / Kyorin Pharmaceutical

Kyorin Pharmaceutical

United States 49 employees 2 duplicate records merged Updated 9 July 2026

Kyorin Pharmaceutical is an API manufacturer based in United States. It holds one active US drug master file across a filed portfolio of 2 molecules. Its filings concentrate with NPRA (MY), ARCSA (EC) and DIGEMAPS (DO).

1
active US DMFs
0
valid CEPs
0
registered plants
4
filings across 3 regulators

What they file, and where

Molecule Regulators Docs
Gatifloxacin US FDA 1
Imidafenacin SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 2 None
ARCSA (EC) 1 None
DIGEMAPS (DO) 1 None

Comparing suppliers?

Choose your molecules and target markets. Kyorin Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability